TY - JOUR
T1 - When to Operate, Hesitate and Reintegrate
T2 - Society of Gynecologic Oncology Surgical Considerations during the COVID-19 Pandemic
AU - Fader, Amanda N.
AU - Huh, Warner K.
AU - Kesterson, Joshua
AU - Pothuri, Bhavana
AU - Wethington, Stephanie
AU - Wright, Jason D.
AU - Bakkum-Gamez, Jamie N.
AU - Soliman, Pamela T.
AU - Sinno, Abdulrahman K.
AU - Leitao, Mario
AU - Martino, Martin A.
AU - Karam, Amer
AU - Rossi, Emma
AU - Brown, Jubilee
AU - Blank, Stephanie
AU - Burke, William
AU - Goff, Barbara
AU - Yamada, S. Diane
AU - Uppal, Shitanshu
AU - Dowdy, Sean C.
N1 - Publisher Copyright:
© 2020 Elsevier Inc.
PY - 2020/8
Y1 - 2020/8
N2 - The COVID-19 pandemic has challenged our ability to provide timely surgical care for our patients. In response, the U.S. Surgeon General, the American College of Srugeons, and other surgical professional societies recommended postponing elective surgical procedures and proceeding cautiously with cancer procedures that may require significant hospital resources and expose vulnerable patients to the virus. These challenges have particularly distressing for women with a gynecologic cancer diagnosis and their providers. Currently, circumstances vary greatly by region and by hospital, depending on COVID-19 prevalence, case mix, hospital type, and available resources. Therefore, COVID-19-related modifications to surgical practice guidelines must be individualized. Special consideration is necessary to evaluate the appropriateness of procedural interventions, recognizing the significant resources and personnel they require. Additionally, the pandemic may occur in waves, with patient demand for surgery ebbing and flowing accordingly. Hospitals, cancer centers and providers must prepare themselves to meet this demand. The purpose of this white paper is to highlight all phases of gynecologic cancer surgical care during the COVID-19 pandemic and to illustrate when it is best to operate, to hestitate, and reintegrate surgery. Triage and prioritization of surgical cases, preoperative COVID-19 testing, peri-operative safety principles, and preparations for the post-COVID-19 peak and surgical reintegration are reviewed.
AB - The COVID-19 pandemic has challenged our ability to provide timely surgical care for our patients. In response, the U.S. Surgeon General, the American College of Srugeons, and other surgical professional societies recommended postponing elective surgical procedures and proceeding cautiously with cancer procedures that may require significant hospital resources and expose vulnerable patients to the virus. These challenges have particularly distressing for women with a gynecologic cancer diagnosis and their providers. Currently, circumstances vary greatly by region and by hospital, depending on COVID-19 prevalence, case mix, hospital type, and available resources. Therefore, COVID-19-related modifications to surgical practice guidelines must be individualized. Special consideration is necessary to evaluate the appropriateness of procedural interventions, recognizing the significant resources and personnel they require. Additionally, the pandemic may occur in waves, with patient demand for surgery ebbing and flowing accordingly. Hospitals, cancer centers and providers must prepare themselves to meet this demand. The purpose of this white paper is to highlight all phases of gynecologic cancer surgical care during the COVID-19 pandemic and to illustrate when it is best to operate, to hestitate, and reintegrate surgery. Triage and prioritization of surgical cases, preoperative COVID-19 testing, peri-operative safety principles, and preparations for the post-COVID-19 peak and surgical reintegration are reviewed.
UR - http://www.scopus.com/inward/record.url?scp=85086153195&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85086153195&partnerID=8YFLogxK
U2 - 10.1016/j.ygyno.2020.06.001
DO - 10.1016/j.ygyno.2020.06.001
M3 - Review article
C2 - 32532460
AN - SCOPUS:85086153195
SN - 0090-8258
VL - 158
SP - 236
EP - 243
JO - Gynecologic Oncology
JF - Gynecologic Oncology
IS - 2
ER -